Drug target · SCN9A
Nav1.7
Voltage-gated sodium channel alpha subunit Nav1.7
1 compound in the CNS pipeline acts on Nav1.7.
Compounds targeting Nav1.7
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| VixotrigineprimarySmall molecule | Inhibitor | — | DiscontinuedNeuropathic pain | Convergence Pharmaceuticals |